Selected research
Market Outlook & Growth Opportunities
Global Medical Device Penetration Testing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Device Penetration Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Penetration Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Device Penetration Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Device Penetration Testing Services market include UL Solutions, TÜV SÜD, Intertek, SGS, atsec, Bureau Veritas Cybersecurity, DEKRA, BSI and MedSec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical Device Penetration Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Device Penetration Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Device Penetration Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Penetration Testing Services market.
Medical Device Penetration Testing Services Segment by Company
UL Solutions
TÜV SÜD
Intertek
SGS
atsec
Bureau Veritas Cybersecurity
DEKRA
BSI
MedSec
MedCrypt
NCC Group
IOActive
Praetorian
NetSPI
Palindrome Technologies
CMD MedTech
Vumetric
Blue Goat Cyber
MedWare Cyber
Sekurno
Centre Testing International Group Co., Ltd.
Shenzhen Academy of Metrology & Quality Inspection
Medical Device Penetration Testing Services Segment by Type
Black-box Dynamic Testing
White-box Code Auditing
Medical Device Penetration Testing Services Segment by Application
Medical Device Manufacturing
In Vitro Diagnostic Equipment
Medical Institutions
Other
Medical Device Penetration Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical Device Penetration Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical Device Penetration Testing Services key companies, revenue, market share, and recent developments.
3. To split the Medical Device Penetration Testing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical Device Penetration Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Device Penetration Testing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Device Penetration Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Penetration Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Penetration Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Penetration Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Penetration Testing Services industry.
Chapter 3: Detailed analysis of Medical Device Penetration Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical Device Penetration Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical Device Penetration Testing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Black-box Dynamic Testing
- White-box Code Auditing
Applications
- Medical Device Manufacturing
- In Vitro Diagnostic Equipment
- Medical Institutions
- Other
Companies covered
- UL Solutions
- TÜV SÜD
- Intertek
- SGS
- atsec
- Bureau Veritas Cybersecurity
- DEKRA
- BSI
- MedSec
- MedCrypt
- NCC Group
- IOActive
- Praetorian
- NetSPI
- Palindrome Technologies
- CMD MedTech
- Vumetric
- Blue Goat Cyber
- MedWare Cyber
- Sekurno
- Centre Testing International Group Co., Ltd.
- Shenzhen Academy of Metrology & Quality Inspection
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Device Penetration Testing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Device Penetration Testing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Penetration Testing Services Market Dynamics
- 2.1 Medical Device Penetration Testing Services Industry Trends
- 2.2 Medical Device Penetration Testing Services Industry Drivers
- 2.3 Medical Device Penetration Testing Services Industry Opportunities and Challenges
- 2.4 Medical Device Penetration Testing Services Industry Restraints
3 Medical Device Penetration Testing Services Market by Company
- 3.1 Global Medical Device Penetration Testing Services Company Revenue Ranking in 2025
- 3.2 Global Medical Device Penetration Testing Services Revenue by Company (2021-2026)
- 3.3 Global Medical Device Penetration Testing Services Company Ranking (2024-2026)
- 3.4 Global Medical Device Penetration Testing Services Company Manufacturing Base and Headquarters
- 3.5 Global Medical Device Penetration Testing Services Company Product Type and Application
- 3.6 Global Medical Device Penetration Testing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical Device Penetration Testing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical Device Penetration Testing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical Device Penetration Testing Services Market by Type
- 4.1 Medical Device Penetration Testing Services Type Introduction
- 4.1.1 Black-box Dynamic Testing
- 4.1.2 White-box Code Auditing
- 4.2 Global Medical Device Penetration Testing Services Sales Value by Type
- 4.2.1 Global Medical Device Penetration Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Device Penetration Testing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Medical Device Penetration Testing Services Sales Value Share by Type (2021-2032)
5 Medical Device Penetration Testing Services Market by Application
- 5.1 Medical Device Penetration Testing Services Application Introduction
- 5.1.1 Medical Device Manufacturing
- 5.1.2 In Vitro Diagnostic Equipment
- 5.1.3 Medical Institutions
- 5.1.4 Other
- 5.2 Global Medical Device Penetration Testing Services Sales Value by Application
- 5.2.1 Global Medical Device Penetration Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Device Penetration Testing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Medical Device Penetration Testing Services Sales Value Share by Application (2021-2032)
6 Medical Device Penetration Testing Services Regional Value Analysis
- 6.1 Global Medical Device Penetration Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Device Penetration Testing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Medical Device Penetration Testing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Medical Device Penetration Testing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Device Penetration Testing Services Sales Value (2021-2032)
- 6.3.2 North America Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical Device Penetration Testing Services Sales Value (2021-2032)
- 6.4.2 Europe Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical Device Penetration Testing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical Device Penetration Testing Services Sales Value (2021-2032)
- 6.6.2 South America Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical Device Penetration Testing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical Device Penetration Testing Services Sales Value Share by Country, 2025 VS 2032
7 Medical Device Penetration Testing Services Country-level Value Analysis
- 7.1 Global Medical Device Penetration Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Device Penetration Testing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Medical Device Penetration Testing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Medical Device Penetration Testing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical Device Penetration Testing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical Device Penetration Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical Device Penetration Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 UL Solutions
- 8.1.1 UL Solutions Company Information
- 8.1.2 UL Solutions Business Overview
- 8.1.3 UL Solutions Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 UL Solutions Medical Device Penetration Testing Services Product Portfolio
- 8.1.5 UL Solutions Recent Developments
- 8.2 TÜV SÜD
- 8.2.1 TÜV SÜD Company Information
- 8.2.2 TÜV SÜD Business Overview
- 8.2.3 TÜV SÜD Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 TÜV SÜD Medical Device Penetration Testing Services Product Portfolio
- 8.2.5 TÜV SÜD Recent Developments
- 8.3 Intertek
- 8.3.1 Intertek Company Information
- 8.3.2 Intertek Business Overview
- 8.3.3 Intertek Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Intertek Medical Device Penetration Testing Services Product Portfolio
- 8.3.5 Intertek Recent Developments
- 8.4 SGS
- 8.4.1 SGS Company Information
- 8.4.2 SGS Business Overview
- 8.4.3 SGS Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 SGS Medical Device Penetration Testing Services Product Portfolio
- 8.4.5 SGS Recent Developments
- 8.5 atsec
- 8.5.1 atsec Company Information
- 8.5.2 atsec Business Overview
- 8.5.3 atsec Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 atsec Medical Device Penetration Testing Services Product Portfolio
- 8.5.5 atsec Recent Developments
- 8.6 Bureau Veritas Cybersecurity
- 8.6.1 Bureau Veritas Cybersecurity Company Information
- 8.6.2 Bureau Veritas Cybersecurity Business Overview
- 8.6.3 Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Bureau Veritas Cybersecurity Medical Device Penetration Testing Services Product Portfolio
- 8.6.5 Bureau Veritas Cybersecurity Recent Developments
- 8.7 DEKRA
- 8.7.1 DEKRA Company Information
- 8.7.2 DEKRA Business Overview
- 8.7.3 DEKRA Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 DEKRA Medical Device Penetration Testing Services Product Portfolio
- 8.7.5 DEKRA Recent Developments
- 8.8 BSI
- 8.8.1 BSI Company Information
- 8.8.2 BSI Business Overview
- 8.8.3 BSI Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 BSI Medical Device Penetration Testing Services Product Portfolio
- 8.8.5 BSI Recent Developments
- 8.9 MedSec
- 8.9.1 MedSec Company Information
- 8.9.2 MedSec Business Overview
- 8.9.3 MedSec Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 MedSec Medical Device Penetration Testing Services Product Portfolio
- 8.9.5 MedSec Recent Developments
- 8.10 MedCrypt
- 8.10.1 MedCrypt Company Information
- 8.10.2 MedCrypt Business Overview
- 8.10.3 MedCrypt Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 MedCrypt Medical Device Penetration Testing Services Product Portfolio
- 8.10.5 MedCrypt Recent Developments
- 8.11 NCC Group
- 8.11.1 NCC Group Company Information
- 8.11.2 NCC Group Business Overview
- 8.11.3 NCC Group Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.11.4 NCC Group Medical Device Penetration Testing Services Product Portfolio
- 8.11.5 NCC Group Recent Developments
- 8.12 IOActive
- 8.12.1 IOActive Company Information
- 8.12.2 IOActive Business Overview
- 8.12.3 IOActive Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.12.4 IOActive Medical Device Penetration Testing Services Product Portfolio
- 8.12.5 IOActive Recent Developments
- 8.13 Praetorian
- 8.13.1 Praetorian Company Information
- 8.13.2 Praetorian Business Overview
- 8.13.3 Praetorian Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Praetorian Medical Device Penetration Testing Services Product Portfolio
- 8.13.5 Praetorian Recent Developments
- 8.14 NetSPI
- 8.14.1 NetSPI Company Information
- 8.14.2 NetSPI Business Overview
- 8.14.3 NetSPI Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.14.4 NetSPI Medical Device Penetration Testing Services Product Portfolio
- 8.14.5 NetSPI Recent Developments
- 8.15 Palindrome Technologies
- 8.15.1 Palindrome Technologies Company Information
- 8.15.2 Palindrome Technologies Business Overview
- 8.15.3 Palindrome Technologies Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Palindrome Technologies Medical Device Penetration Testing Services Product Portfolio
- 8.15.5 Palindrome Technologies Recent Developments
- 8.16 CMD MedTech
- 8.16.1 CMD MedTech Company Information
- 8.16.2 CMD MedTech Business Overview
- 8.16.3 CMD MedTech Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.16.4 CMD MedTech Medical Device Penetration Testing Services Product Portfolio
- 8.16.5 CMD MedTech Recent Developments
- 8.17 Vumetric
- 8.17.1 Vumetric Company Information
- 8.17.2 Vumetric Business Overview
- 8.17.3 Vumetric Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Vumetric Medical Device Penetration Testing Services Product Portfolio
- 8.17.5 Vumetric Recent Developments
- 8.18 Blue Goat Cyber
- 8.18.1 Blue Goat Cyber Company Information
- 8.18.2 Blue Goat Cyber Business Overview
- 8.18.3 Blue Goat Cyber Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Blue Goat Cyber Medical Device Penetration Testing Services Product Portfolio
- 8.18.5 Blue Goat Cyber Recent Developments
- 8.19 MedWare Cyber
- 8.19.1 MedWare Cyber Company Information
- 8.19.2 MedWare Cyber Business Overview
- 8.19.3 MedWare Cyber Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.19.4 MedWare Cyber Medical Device Penetration Testing Services Product Portfolio
- 8.19.5 MedWare Cyber Recent Developments
- 8.20 Sekurno
- 8.20.1 Sekurno Company Information
- 8.20.2 Sekurno Business Overview
- 8.20.3 Sekurno Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Sekurno Medical Device Penetration Testing Services Product Portfolio
- 8.20.5 Sekurno Recent Developments
- 8.21 Centre Testing International Group Co., Ltd.
- 8.21.1 Centre Testing International Group Co., Ltd. Company Information
- 8.21.2 Centre Testing International Group Co., Ltd. Business Overview
- 8.21.3 Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.21.4 Centre Testing International Group Co., Ltd. Medical Device Penetration Testing Services Product Portfolio
- 8.21.5 Centre Testing International Group Co., Ltd. Recent Developments
- 8.22 Shenzhen Academy of Metrology & Quality Inspection
- 8.22.1 Shenzhen Academy of Metrology & Quality Inspection Company Information
- 8.22.2 Shenzhen Academy of Metrology & Quality Inspection Business Overview
- 8.22.3 Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Revenue and Gross Margin (2021-2026)
- 8.22.4 Shenzhen Academy of Metrology & Quality Inspection Medical Device Penetration Testing Services Product Portfolio
- 8.22.5 Shenzhen Academy of Metrology & Quality Inspection Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst